From Polypharmacology to Target Specificity: The Case of PARP Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 23, 2013-12 ,pp. : 2939-2954

Bentham Science Publishers

Access to resources Recommend Favorite

Target specificity and off-target effects as determinants of cancer drug efficacy

By Shoshan Maria C   Linder Stig  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 3, 2008-03 ,pp. : 273-280

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target

By Choi Dong Kug   Koppula Sushruta   Choi Mijung   Suk Kyoungho  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. : 1531-1546

Informa Healthcare

Access to resources Recommend Favorite

Mechanism and Potential Inhibitors of GlmU: A Novel Target for Antimicrobial Drug Discovery

By  

Current Drug Targets, Vol. 18, Iss. 14, 2017-10 ,pp. : 1587-1597

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis as a therapeutic target in cancer

By Kumaran Gireesh   Clamp Andrew R   Jayson Gordon C  

Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. : 455-458

Royal College Of Physicians

Access to resources Recommend Favorite